CID 3081884

Base Information

• Chemical Name: CID 3081884
• CAS No.: 147245-92-9
• Molecular Formula: (C9H11NO3.C6H14N2O2.C5H9NO4.C3H7NO2)x.xC2H4O2
• Molecular Weight: 623.65000
• European Community (EC) Number: 814-981-5
• DSSTox Substance ID: DTXSID30163637
• Wikipedia: Glatiramer_acetate
• Wikidata: Q418274
• NCI Thesaurus Code: C65805
• RXCUI: 84375
• Mol file: 147245-92-9.mol

Synonyms:5010, TV;Acetate, Glatiramer;Copaxone;Glatiramer;glatiramer acetate;TV 5010;TV-5010;TV5010

Chemical Property of CID 3081884

Chemical Property:

• Vapor Pressure: 1.27E-06mmHg at 25°C
• Boiling Point: 385.2oC at 760mmHg
• Flash Point: 186.7oC
• PSA: 374.13000
• LogP: 2.14760
• Storage Temp.: Refrigerator
• Solubility.: Methanol (Slightly), Water (Slightly)
• Hydrogen Bond Donor Count: 12
• Hydrogen Bond Acceptor Count: 18
• Rotatable Bond Count: 13
• Exact Mass: 623.30138651
• Heavy Atom Count: 43
• Complexity: 519

Purity/Quality:

≥98% ^*data from raw suppliers

Glatiramer Acetate ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
• Isomeric SMILES: C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N
• Recent ClinicalTrials: Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) 'Prevention of Relapse of Multiple Sclerosis'
• Recent EU Clinical Trials: An Open-Label, Rater-Blind, Randomized, Multi-Center, Parallel-Arm, Active-Comparator Study to Assess the Efficacy and Tolerability of Ofatumumab 20mg SC monthly vs. First Line DMT-physician’s choice in the treatment of newly diagnosed RMS
• Recent NIPH Clinical Trials: Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) 'Prevention of Relapse of Multiple Sclerosis'
• Uses: Glatiramer acetate is a random basic synthetic copolymer of L-alanine, L-lysine, l-glutamic acid and L-tyrosine in a molar ratio of 6:1.9:4.7:1. Glatiramer acetate is an immunomodulator used in treatment of multiple sclerosis. Glatiramer Acetate-Dx is labelled Glatiramer Acetate (G406800) which is a random basic synthetic copolymer of L-alanine, L-lysine, l-glutamic acid and L-tyrosine. Glatiramer acetate is an immunomodulator used in treatment of multiple sclerosis.
• Clinical Use: Immunomodulating drug: Treatment for patients at a high risk of developing multiple sclerosis and for reduction in relapses in ambulatory patients
• Drug interactions: Potentially hazardous interactions with other drugs None known